股票 › SMMT
顶峰治疗 SMMT
$16.33 +$2.14 (+15.08%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $16.30 -0.18%
开盘$14.79
昨收$14.19
当日区间$14.66 – $16.36
成交量5.80M
市值$13.06B
市盈率（TTM）–
股息率–
SMMT 相关新闻
匹配 Summit Therapeutics 或代码 SMMT 的头条新闻，按最新排序。
- Jefferies Upgrades Summit Therapeutics(SMMT.US) to Buy Rating, Raises Target Price to $25 正面
- A Quick Look at Today's Ratings for Summit Therapeutics(SMMT.US), With a Forecast Between $16 to $43
- Clear Street Initiates Summit Therapeutics(SMMT.US) With Buy Rating, Announces Target Price $31
- H.C. Wainwright Maintains Summit Therapeutics(SMMT.US) With Hold Rating
- Barclays Maintains Summit Therapeutics(SMMT.US) With Hold Rating, Maintains Target Price $18
- UBS Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $33
- Citi Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $40
- Goldman Sachs Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $41
- Wells Fargo Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $30
- Wolfe Research Initiates Summit Therapeutics(SMMT.US) With Hold Rating
- Bernstein Maintains Summit Therapeutics(SMMT.US) With Sell Rating, Maintains Target Price $9.8
- Stifel Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $38
- TD Cowen Maintains Summit Therapeutics(SMMT.US) With Buy Rating
- A Quick Look at Today's Ratings for Summit Therapeutics(SMMT.US), With a Forecast Between $15 to $40
- A Quick Look at Today's Ratings for Summit Therapeutics(SMMT.US), With a Forecast Between $16 to $40
暂无评论——快来第一个聊聊 SMMT。
登录后参与讨论。